At this point, bad news is coming in consistently to the point that any significant piece of good news could catapult the stock higher, making Sanofi an interesting choice for dip-buyers. The latest setback the company has had stems from …
Is Sanofi SA (ADR) (NYSE:SNY) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, expert networks, …
Sanofi's stock (see graph) seems not to have recovered from reports that Lantus was linked to cancer, even though Sanofi obtained an approval for a new heart drug, Multaq. Meanwhile, Sanofi's rivals are happily spraying the fire with …
Sanofi Launches "Action 2017", a Worldwide Employee Stock Purchase Plan Paris, France - June 15, 2017 - Sanofi (http://en.sanofi.com/index.aspx) announced today the launch of "Action 2017", a worldwide stock purchase plan …
Shares of Sanofi SA (SNYNF,SNY) were gaining around 2 percent in the early morning trading in Paris after the French drug giant reported Friday significantly higher profit in its first quarter, benefited by 4.4 billion euros gains from the …
Genzyme argued that the drug Lemtrada's market potential was not being recognized in Sanofi's offering price. After months of back and forth, the two sides agreed on a compromise: a tracking stock that allowed investors to make an …
“This is a setback for the company’s most important growth driver of recent years,” said Berenberg analyst Alistair Campbell, who has a “hold” rating on Sanofi stock. Sanofi stuck to its 2014 profit forecast despite weaker-than …
Sanofi and MannKind launched a $925 million partnership in 2014 to market Afrezza, an inhalable form of insulin, shortly after it was approved. (For more, see Is This Diabetes Stock a Better Bet Than MannKind?) At the time, the market for …
Paris, France - June 15, 2017 - Sanofi announced today the launch of "Action 2017", a worldwide stock purchase plan reserved for its employees. In doing such a capital increase, Sanofi intends to better associate its employees with the …